Emerging Trends to Reshape the Global Expanded Carrier Screening Market: Advancing Genetic Testing With High-Accuracy Multi-Gene Panels For Inherited Disorder Detection as a Key Influencer

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Expanded Carrier Screening Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for expanded carrier screening has been experiencing a swift expansion in recent years. Its growth is projected to increase from $2.11 billion in 2024 to $2.46 billion in 2025, with a compound annual growth rate (CAGR) of 16.9%. The remarkable growth recorded in the historic period can be credited to several factors such as the increasing consciousness about genetic disorders, the escalating availability of genetic counselling services, the growing requirement for early diagnosis in reproductive health, the proliferation of prenatal and preconception testing programs, and a heightened preference for preventive healthcare.

Expanded Carrier Screening Market Size Forecast: What's the Projected Valuation by 2029?
A surge in growth is anticipated in the size of the expanded carrier screening market in the upcoming years, projecting an escalation to $4.54 billion in 2029 and a 16.5% compound annual growth rate (CAGR). Various factors such as the growing demand for individualized reproductive medicine, increasing acceptance of expanded carrier screening in developing markets, wider consumer access to home-based genetic testing kits, the rise in genetic testing benefits endorsed by employers, and the escalating need to identify carriers within multicultural societies are contributing to the predicted growth during the forecast period. Notably, the forecast phase will be characterized by progress in next-generation sequencing technology, the creation of artificially intelligent genetic risk prediction models, the development of point-of-care genetic testing platforms, integration with electronic health record systems, and the invention of innovative multiplexed genetic testing platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

What Are the Drivers Transforming the Expanded Carrier Screening Market?
The increasing occurrence of genetic disorders is projected to drive the growth of the expanded carrier screening market in the future. Genetic disorders result from irregularities or mutations in a person's DNA, and they can either be hereditary or spontaneously occur. Advancements in diagnostic tools, notably next-generation sequencing and other genomic technologies, have significantly enhanced the identification and detection of numerous genetic disorders that had previously been undetected or misdiagnosed. Expanded carrier screening facilitates the detection of genetic disorder carriers prior to the appearance of symptoms. This allows for more informed reproductive decisions and lowers the probability of passing on inherited disorders to future generations. For example, Cystic Fibrosis Trust, a UK charity supporting individuals with cystic fibrosis reported in October 2024 that while 11,148 cystic fibrosis patients were registered in 2022, in 2023, the figures grew to 11,318. This represented a 1.5% year-over-year increase in patient registrations. As such, the escalating occurrence of genetic diseases proves to be a catalyst for the growth of the carrier screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28215&type=smp

What Long-Term Trends Will Define the Future of the Expanded Carrier Screening Market?
Leading businesses in the expanded carrier screening market are concentrating on creating innovative solutions like comprehensive next-generation sequencing-based panels. These panels can identify a vast array of genetic disorders with heightened accuracy and efficiency. Comprehensive next-generation sequencing (NGS)-based panels are cutting-edge genetic tests that examine numerous genes at once, capable of identifying a wide variety of inherited diseases swiftly and accurately. For example, Fulgent Genetics Inc., a genomic testing firm based in the US, introduced the Beacon787 Expanded Carrier Screening Panel in February 2023. This panel, designed to assess 787 genes associated with severe inherited diseases, provides wide coverage of over 700 autosomal recessive and X-linked disorders, including all Tier 3 genes. It employs advanced next-generation sequencing technology enabling high analytical accuracy, a pan-ethnic approach, and a rapid turnaround time of 2-3 weeks, setting it apart as one of the most comprehensive and precise solutions for reproductive carrier screening available.

Which Segments in the Expanded Carrier Screening Market Offer the Most Profit Potential?
The expanded carrier screening market covered in this report is segmented as

1) By Types: Customized Panel Testing, Predesigned Panel Testing
2) By Technology: Deoxyribonucleic Acid Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies
3) By Application: Preconception, Prenatal, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Laboratories, Specialty Clinics, Other End-Users

Subsegments:
1) By Customized Panel Testing: Single Gene Testing, Multi-Gene Panel Testing, Ethnicity-Based Custom Panels, Condition-Specific Custom Panels, Family History-Based Custom Panels
2) By Predesigned Panel Testing: Pan-Ethnic Panels, Universal Carrier Panels, Population-Specific Panels, Disorder-Focused Panels, Expanded Predefined Panels

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28215&type=smp

Which Firms Dominate the Expanded Carrier Screening Market by Market Share and Revenue in 2025?
Major companies operating in the expanded carrier screening market are Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BGI Genomics Co. Ltd., Ambry Genetics Corporation, GeneDx Inc., BillionToOne Inc., MedGenome Labs Ltd., Centogene N.V., Baylor Miraca Genetics Laboratories LLC, Victorian Clinical Genetics Services, Pathkind Diagnostics Private Limited, Medicover Genetics GmbH, NxGen MDx LLC, GeneTech

Which Regions Offer the Highest Growth Potential in the Expanded Carrier Screening Market?
North America was the largest region in the expanded carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in expanded carrier screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28215

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.